1215 studies found for:    LEUKEMIA, CHRONIC MYELOID
Show Display Options
Rank Status Study
1 Not yet recruiting Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia
Conditions: Chronic Phase Chronic Myeloid Leukemia;   Accelerated Phase Chronic Myeloid Leukemia;   Blastic Phase Chronic Myeloid Leukemia;   Philadelphia Positive Acute Lymphoblastic Leukemia;   Resistant to Tyrosine Kinase Inhibitor Therapy
Interventions: Drug: Nilotinib;   Drug: Ruxolitinib
2 Completed Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Conditions: Chronic Myeloid Leukemia;   Leukemia, Lymphoblastic, Acute, Philadelphia-positive
Intervention: Drug: Dasatinib
3 Completed
Has Results
Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia
Conditions: Chronic Myeloid Leukemia;   Philadelphia-Positive Myeloid Leukemia
Interventions: Drug: Dasatinib;   Drug: Imatinib
4 Completed
Has Results
Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
Conditions: Chronic Myeloid Leukemia;   Philadelphia-Positive Myeloid Leukemia
Intervention: Drug: Dasatinib
5 Completed Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy
Condition: Chronic Myeloid Leukemia
Intervention: Biological: Autologous CIK cell infusion
6 Unknown  A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Drug: dasatinib
7 Unknown  Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia
Conditions: Myelodysplastic Syndrome;   Myelofibrosis;   Chronic Myeloid Leukemia;   Chronic Lymphocytic Leukemia
Interventions: Drug: Luitpold Azacitidine;   Drug: Vidaza®
8 Active, not recruiting Patient Reported Outcomes in Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Other: HRQOL questionnaire
9 Completed Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Nilotinib, interferon-alfa
10 Terminated Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
Conditions: Chronic Myeloid Leukemia;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Intervention: Drug: XL228
11 Recruiting Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Other: Echo, exercise echo, and if indicated, right heart catheter
12 Not yet recruiting LEONIDAS: Quality of Life Study in Chronic Myeloid Leukemia Patients
Condition: Chronic Myeloid Leukemia
Intervention: Other: QoL Survey Booklet
13 Recruiting Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Nilotinib
14 Unknown  A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib
Condition: Chronic Myeloid Leukemia
Intervention: Drug: dasatinib
15 Completed
Has Results
Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease
Conditions: Chronic Myeloid Leukemia;   Minimal Residual Disease
Intervention: Biological: Synthetic Tumor-Specific Breakpoint Peptide Vaccine
16 Recruiting TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Imatinib/Nilotinib
17 Recruiting Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib
Condition: Chronic Myeloid Leukemia
Intervention: Behavioral: Dasatinib discontinuation
18 Terminated Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients
Condition: Chronic Myeloid Leukemia
Interventions: Drug: Placebo;   Drug: Armodafinil
19 Completed Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Nilotinib
20 No longer available Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Drug: AMN107

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years